Navigation Links
Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
Date:8/26/2009

LACHEN, Switzerland and HOBOKEN, N.J., Aug. 26 /PRNewswire/ -- Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, combined with Octapharma's efforts to pursue the first recombinant FVIII therapy produced from a human cell line, could dramatically impact the treatment of an estimated one in every 5,000 to 10,000 men born with hemophilia A worldwide. Globally, 75% of the hemophilia cases go undiagnosed or untreated.

Octapharma AG, the third largest plasma products manufacturer in the world, recently brought together many of the most respected blood coagulation disorder researchers for two symposia on this important issue during the International Society on Thrombosis and Haemostasis (ISTH) Biennial Congress in Boston. Octapharma was one of only five Platinum Sponsors at the ISTH Congress, which attracted approximately 7,500 representatives of the medical and research community as well as many patients.

Clinical experts noted during the symposia that up to 40 percent of previously untreated patients (PUPs) with hemophilia A develop the most serious clinical complication of FVIII replacement therapy - inhibitory antibodies - which can result in uncontrolled hemorrhage, increased hospitalizations and joint damage, resulting in increased morbidity and mortality.

"We brought the international community together to confront this issue because our worldwide commitment to hemophilia A patients dates back to Octapharma's formation 25 years ago," said Octapharma AG Vice Chairman '/>"/>

SOURCE Octapharma AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
2. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
5. Raptor Pharmaceuticals Provides Update on Targeting Platforms
6. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
7. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
8. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
9. Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease
10. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
11. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Mass. , Aug. 29, 2014  A ... prospective, multinational study on stent removability and preliminary ... has been published in the August issue of ... multinational study 1 is being conducted in ... of fully covered self-expanding metal stents (FCSEMS) after ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... 2014 Research and Markets has ... Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the ... landscape, and business performance of domestic major enterprises, as ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4China Orthopedic Instrument Industry Report, 2014-2017 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... For Landmark Study To Measure Effects Of Music ... Hospital System today announced that it has received ... support a groundbreaking study that will measure the ... patients with diabetes.Lake Hospital System is seeking 200-300 ...
... Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical ... that BioSpecifics, President, Tom Wegman, will present a corporate ... Health Care Conference on Tuesday, March 17, 2009, at ... Boston, MA. A live webcast of the presentation can ...
Cached Medicine Technology:Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study 2Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study 3Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study 4
(Date:8/29/2014)... The Fibroids Miracle review indicates that this is a new ... and powerful results. It actually claims to be able to ... 12 hours. The method promises to lead to a permanent ... on a 3 step method that has never been revealed ... was in fact created by someone who had an important ...
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica ... method of naturally curing this disease. , The program ... permanent cure in only one week. This is described as ... make huge sacrifices. , Moreover, with this new method ... of sciatica in just 8 minutes. , Interested customers ...
(Date:8/29/2014)... Skmen.com, a famous online supplier of trendy clothes, has unveiled ... the moment, all these mini outfits are offered at discounted ... promotion is September 14. , The company’s senior spokesman ... our hot designs, we have listed some of the best-selling ... stylish ladies to get high quality, fashionable clothes. Many of ...
(Date:8/29/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... licensing of its Q-Suite 5.7 software. As a ... been successfully deploying and supporting its ACD and Dialer ... the world for more than a decade. The introduction ... option which complements the widespread deployment of Q-Suite in ...
(Date:8/29/2014)... 2014 Developed as a nod to ... Canada Goose products offer the mobility, durability ... Arctic runways. The company’s Canada Goose Chilliwack bombers ... current market. Additionally, the firm has unveiled its new ... , At present, all high quality Chilliwack bombers are ...
Breaking Medicine News(10 mins):Health News:Fibroids Miracle Review Exposes Amanda Leto’s 3-Step Holistic System 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2
... to raise awareness of the National Marrow Donor Program , ... ... Marrow Donor Program® (NMDP) and Preston Kelly, an independent agency in ... to increase awareness of the importance of joining the Be The ...
... EHRtv on EHR implementation and the state of Healtcare IT in ... ... 24, 2009 -- EHRtv.com, the newly launched website for Comprehensive Video ... interview Former Representative Richard Gephardt during the Recent HIMSS09 Health IT ...
... Khanna institute of Lasik gives back to the community and helps ... ... Village, CA (PRWEB) April 24, 2009 -- Oaks Christian is an ... village. Recently, The Khanna Institute supported their efforts and ...
... in the Lungs , A group led by Dr. ... as a mediator of lung fibrosis. They present their data in ... . , Scar tissue, or fibrosis, can accumulate in ... lung disease, respiratory failure, and eventually death. An increase in ...
... World Malaria Day Events Held in Nairobi , ... Washington LAUSANNE, Switzerland, ... on 4/25, ,Counting Malaria Out, Vestergaard Frandsen is stepping up ... a new version that is effective against insecticide resistant mosquitoes. Malaria ...
... might be replicated for heart disease, scientists say, , , THURSDAY, ... patient,s own skin cells to grow tissue-engineered shunts for dialysis ... The problem right now is that about half of all ... via a plastic tube that creates a shunt -- a ...
Cached Medicine News:Health News:Be The MatchSM Brand Campaign Launches 2Health News:Be The MatchSM Brand Campaign Launches 3Health News:Representative Richard Gephardt Sits Down With EHRtv.com 2Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Tips from the American Journal of Pathology 2Health News:Tips from the American Journal of Pathology 3Health News:Tips from the American Journal of Pathology 4Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 2Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 2Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: